Androgen related primary hepatic tumors in non-Fanconi patients
Open Access
- 15 May 1983
- Vol. 51 (10) , 1947-1952
- https://doi.org/10.1002/1097-0142(19830515)51:10<1947::aid-cncr2820511034>3.0.co;2-5
Abstract
Three cases of androgen related primary hepatic tumor in non‐Fanconi patients are described in whom detailed information is available concerning histologic changes and clinical course over long periods. Two patients presented with hepatic rupture and hemoperitoneum requiring surgical intervention. In one case histologic assessment showed a hepatic adenoma which has almost completely regressed over four years since androgen withdrawal. In two patients there was a degree of nuclear pleomorphism not seen in ‘spontaneous’ adenomas and following androgen withdrawal there has been no evidence of progression or of metastases although the tumor has not regressed over a follow‐up period of two years.This publication has 10 references indexed in Scilit:
- Spontaneous rupture of a liver cell adenoma after long term Methyltestosterone: Report of a case successfully treated by emergency right hepatic lobectomyBritish Journal of Surgery, 1979
- Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven yearsCancer, 1977
- Benign liver-cell adenoma associated with long-term administration of an androgenic-anabolic steroid (methandienone)Cancer, 1977
- LIVER DAMAGE FROM LONG-TERM METHYLTESTOSTERONEThe Lancet, 1977
- Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosteronetherapy: possible relationships of these changes to the development of peliosis hepatis and liver tumoursHistopathology, 1977
- Fulminant Hepatic Neoplasia after Androgen TherapyNew England Journal of Medicine, 1977
- LIVER-DAMAGE FROM LONG-TERM METHYLTESTOSTERONE1977
- Liver Nodules and AndrogensThe Lancet, 1976
- ANDROGEN-INDUCED HEPATOMAThe Lancet, 1975
- Peliosis Hepatis Associated with Androgenic-Anabolic Steroid TherapyAnnals of Internal Medicine, 1974